NHS DigiTrials will help NHS patients across the length and breadth of England participate in clinical trials of new treatments. The results generated will influence the day-to-day care of millions of future NHS patients with a wide range of conditions, as well as supporting planning and research into COVID-19.
We have created the NHS DigiTrials Service to provide data, expertise and infrastructure specific for clinical trials.
We aim to:
- Enable more opportunities for participation in research
- Reduce the cost and complexity of developing new treatments
- Reduce drug costs to the NHS improve the quality of evidence on the effectiveness and safety of new treatments for patients and their doctors.
NHS DigiTrials’ vision is to create and provide service that provides clear benefits at the right time and in the right way for its customers. Recognising that clinical trials will be focused on COVID-19 for the foreseeable future, it is currently looking at the need for outcome data to support this vital work – namely data about clinical interventions and their results across a range of care settings.
Focusing on outcomes data will better address current clinical trial needs and is central to our vision of creating a service that provides clear benefits at the right time and in the right way.